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Clinical illness caused by Rickettsia rickettsii in dogs 
has been reported solely in the United States. We report 
2 natural clinical cases of Rocky Mountain spotted fever in 
dogs in Brazil. Each case was conﬁ  rmed by seroconver-
sion and molecular analysis and resolved after doxycycline 
therapy.
R
ickettsia rickettsii, the etiologic agent of Rocky Moun-
tain spotted fever (RMSF), is the most pathogenic of 
the rickettsiae for humans and some animals. RMSF has 
been reported in North, Central, and South America, where 
different tick species serve as vectors (1). Although sero-
logic studies among healthy dogs in Brazil have indicated 
past infection by R. rickettsii (2,3), clinical illness caused 
by R. rickettsii in dogs has been reported solely in the Unit-
ed States (4,5).
In Brazil, the most common vector-borne disease of 
dogs is canine monocytic ehrlichiosis (CME), caused by 
Ehrlichia canis (6). Clinical signs (fever, depression, pete-
chial hemorrhages, thrombocytopenia) in dogs with overt 
RMSF infection or CME are often similar (5). Doxycycline 
is the treatment of choice for R. rickettsii infection in dogs 
(7) and the most commonly prescribed treatment for CME 
in Brazil. Thus, clinical cases of RMSF among dogs in Bra-
zil could be being misdiagnosed as CME. We describe 2 
natural cases of RMSF in dogs in Brazil.
The Cases
On August 23, 2007, a 4-year-old, female, Dogue de 
Bordeaux (dog 1) was brought to a veterinary clinic in São 
Paulo because of a high load of ticks noticed 5 days after 
she had been to a farm in the Itu Municipality (23°15′S, 
47°17′W), state of São Paulo. The dog was treated with 
ﬁ  pronil and sent home. Tick taxonomic identiﬁ  cation was 
not performed. The next day, the dog had diarrhea and he-
matochezia and was taken back to the clinic, where labora-
tory test results were within reference ranges, except for 
a slight leukocytosis (18,000 cells/mm3) and elevated al-
kaline phosphatase level (278.6 U/L). Metronidazol was 
prescribed, and the dog was again sent home. Three days 
later, the dog was febrile (40.5°C), anorexic, and lethar-
gic. Blood was sent to a private laboratory, where a battery 
of PCR tests failed to detect DNA of Babesia spp., Borre-
lia spp., Mycoplasma spp., or Ehrlichia spp. The dog was 
treated with subcutaneous imidocarb and oral doxycycline. 
The next day, the dog was still febrile (39.4°C) and anorex-
ic, and neurologic signs (ataxia and vestibular syndrome 
with spontaneous nystagmus) had developed. The animal 
was hospitalized; doxycycline was switched to the subcu-
taneous route; and the next day oral prednisone was added. 
Blood values remained within reference range, except for 
a slight leukocytosis (17,600 cells/mm3). On August 30, 
neurologic improvement was noted, and the dog had no fe-
ver (38.5°C) and started to eat. Despite slight nystagmus, 
the dog was discharged the next day. On September 3, (8 
days after doxycycline therapy began), the dog showed no 
clinical abnormality, and a new blood sample was collected 
for serologic testing. Another blood sample collected on 
September 10 showed hematologic parameters within ref-
erence range except for leukopenia (6,900 cells/mm3).
Serologic evaluation was performed by indirect immu-
noﬂ  uorescence assay (IFA) by using antigens of 6 Rickett-
sia isolates from Brazil (8). Plasma from the sample col-
lected on August 24 showed an IFA endpoint titer of 128 
for R. rickettsii and no reactivity for the remaining rick-
ettsial antigens at a 1:64 dilution. Plasma from the sample 
collected on September 3 showed the following endpoint 
titers for rickettsial antigens: R. rickettsii 2,048, R. parkeri 
512, R. amblyommii 512, R. felis 512, R. rhipicephali, and 
512; R. bellii 256.
DNA was extracted from the blood samples collect-
ed on August 24 and September 3 (before and after anti-
microbial drug therapy) by using the DNeasy Tissue Kit 
(QIAGEN, Chatsworth, CA, USA). Samples were tested 
by 2 PCR protocols: one targeting a 147-bp fragment of the 
rickettsial gltA gene (9), and the other, a heminested PCR, 
targeting a fragment of the rickettsial ompA gene (10). Ex-
tracted DNA from the ﬁ  rst blood sample yielded expected 
products by both PCR protocols. No product was obtained 
from the second blood sample. Sequencing of the ompA 
product resulted in a 452-bp fragment 100% identical to 
the corresponding sequence of the Bitterroot strain of R. 
rickettsii from the United States (GenBank accession no. 
U43804). Ehrlichia spp. were not detected by PCR (6) in 
either sample.
The second case was noted on August 28, 2007, when 
a 10-month-old, female, miniature Schnauzer (dog 2) was 
examined at the same veterinary clinic for anorexia, leth-
argy, fever (40.2°C), vomiting, and tick infestation. This 
dog had visited the same farm at the same time as dog 1. 
No neurologic signs were observed. Dog 2 was treated with 
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ﬁ  pronil and sent home with atropine, imizol, ranitidine, 
dipirone, and doxycycline. Blood collected on August 28 
had values within reference ranges, except for thrombocy-
topenia (thrombocytes 150,000/mm3). IFA for rickettsial 
antigens showed no reactivity at the 1:64 dilution for the 
6 rickettsial antigens, but serum from a second sample col-
lected on September 3 (when the dog was showing no clini-
cal signs) showed the following endpoint titers: R. rickettsii 
4,096 R. parkeri 512, R. amblyommii 512, R. felis 256, R. 
rhipicephali 256, and R. bellii 256.
DNA was extracted from the samples collected on Au-
gust 24 and September 3 (before and after antimicrobial 
drug therapy) and processed by the PCR protocols cited 
above. Extracted DNA from the ﬁ  rst sample yielded ex-
pected product for the gltA-PCR, which was not sequenced. 
No other PCR product was obtained.
Conclusions
Deﬁ  nitive diagnoses of naturally acquired R. rickettsii 
infection in 2 dogs in Brazil are supported by 1) paired se-
rum samples with >8-fold rise in antibody titer to R. rick-
ettsii antigen; 2) titers to R. rickettsii >4-fold higher than 
titers to other rickettsial antigens known to occur in Brazil; 
3) detection of rickettsial DNA in canine blood, conﬁ  rmed 
to be R. rickettsii in at least 1 of the dogs; 4) compatible 
clinical signs and laboratory abnormalities (i.e., thrombo-
cytopenia in at least 1 dog); 5) response to doxycycline; 
and 6) compatible epidemiologic history (i.e., prior con-
tact with ticks in an RMSF-endemic area). This sixth state-
ment is supported by the fact that Itu municipality is an 
area where RMSF laboratory-conﬁ  rmed cases in humans 
have been reported since 2003 (www.cve.saude.sp.gov.br). 
Owners of the 2 dogs reported here noted various capybaras 
(Hydrochoerus hydrochaeris) in the area where their dogs 
had become infested with ticks (data not shown). Capyba-
ras are one of the main hosts of Amblyomma cajennense 
ticks, the most common important vector of R. rickettsii in 
Brazil (9,11).
In a recent study of experimental infection, dogs ex-
posed to a Brazil isolate of R. rickettsii had fever, lethargy, 
anorexia, anemia, and thrombocytopenia; 1 also had ocular 
lesions (12). These clinical signs have been reported in the 
United States for dogs with active R. rickettsii infection 
(4,5) and were also noted in the present study under natural 
conditions, except for anemia and ocular lesions. Studies in 
the United States have shown that neurologic dysfunction 
occurs in as many as 43% of dogs with RMSF; vestibular 
dysfunction is possibly the most frequent neurologic ab-
normality (13). These results suggest that clinical illness 
caused by R. rickettsii in dogs has similar patterns in Brazil 
and the United States.
Veterinarians in Brazil should include R. rickettsii in-
fection in their differential diagnoses of CME and other 
acute nonspeciﬁ  c febrile illnesses of dogs, especially be-
cause R. rickettsii is highly pathogenic for humans. In the 
United States, several cases of human infection have been 
preceded by RMSF in dogs (14,15). Accurate diagnosis of 
RMSF in dogs should lead to dog owners understanding 
risk for infection from ticks in their location (14) and pro-
vide valuable information for the surveillance of RMSF in 
humans.
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